Sun Jul 1, 2012, 12:37 PM
2on2u (1,843 posts)
Easter Island Drug Raises Cognition Throughout Life Span in Mice
Looks like the aliens left us something to ponder upon.
http://www.sciencedaily.com/releases/2012/06/120629211902.htm ScienceDaily (June 29, 2012) — Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.
The researchers, appointed in the School of Medicine at The University of Texas Health Science Center San Antonio, added rapamycin to the diet of healthy mice throughout the rodents' life span. Rapamycin, a bacterial product first isolated from soil on Easter Island, enhanced learning and memory in young mice and improved these faculties in old mice, the study showed. "We made the young ones learn, and remember what they learned, better than what is normal," said Veronica Galvan, Ph.D., assistant professor of physiology at the Barshop Institute for Longevity and Aging Studies, part of the UT Health Science Center. "Among the older mice, the ones fed with a diet including rapamycin actually showed an improvement, negating the normal decline that you see in these functions with age." The drug also lowered anxiety and depressive-like behavior in the mice, Dr. Galvan said. Anxiety and depression are factors that impair human cognitive performance. Lead author Jonathan Halloran conducted scientifically reliable tests to accurately measure these cognitive components in the rodents.
|
16 replies, 1360 views
| Author | Time | Post | |
| 2on2u | Jul 2012 | OP | |
| ZombieHorde | Jul 2012 | #1 | |
| TheWraith | Jul 2012 | #3 | |
| 2on2u | Jul 2012 | #6 | |
| TheWraith | Jul 2012 | #8 | |
| 2on2u | Jul 2012 | #9 | |
| 2on2u | Jul 2012 | #11 | |
| aint_no_life_nowhere | Jul 2012 | #2 | |
| IDemo | Jul 2012 | #5 | |
| thelordofhell | Jul 2012 | #7 | |
| 2on2u | Jul 2012 | #10 | |
| Auntie Bush | Jul 2012 | #4 | |
| Quantess | Jul 2012 | #12 | |
| SidDithers | Jul 2012 | #13 | |
| 2on2u | Jul 2012 | #14 | |
| zappaman | Jul 2012 | #15 | |
| 2on2u | Jul 2012 | #16 |
Response to 2on2u (Original post)
Sun Jul 1, 2012, 12:40 PM
ZombieHorde (23,826 posts)
1. Seems too good to be true.
|
Is Science Daily a reputable source?
|
Response to ZombieHorde (Reply #1)
Sun Jul 1, 2012, 01:10 PM
TheWraith (24,331 posts)
3. Press releases always sound that way.
|
It's not until later that you find out what they're advertising turned out to be impractical to mass manufacture, or have major drawbacks, or end up being ten times as expensive as they thought.
|
Response to TheWraith (Reply #3)
Sun Jul 1, 2012, 01:14 PM
2on2u (1,843 posts)
6. They are in phase two of a clinical trial with resveratrol and currently recruiting
|
http://www.clinicaltrials.gov/ct2/show/NCT01504854?term=alzheimer%27s&rank=13
Resveratrol is derived from plants and is found in highest levels in red wine and the skin of red grapes. A recent study reported that monthly and weekly consumption of red wine is associated with a lower risk of dementia. There is compelling evidence that caloric restriction can improve overall health by activating a class of enzymes known as Sirtuins. Resveratrol is a substance found in some plants that directly activates sirtuins, mimicking the effects of caloric restriction and may affect regulatory pathways of diseases of aging, including Alzheimer's disease (AD). In this study, people with AD will be given either Resveratrol or placebo for 12 months to determine whether daily resveratrol therapy is beneficial in delaying or altering the deterioration of memory and daily functioning. Subjects age 50 and above with a diagnosis of probable AD may qualify for participation in this study. A small group of 15 participants will be asked to take part in a more detailed 24-hour Pharmacokinetic (PK) sub-study that will measure resveratrol levels over a 24 hour period. |
Response to 2on2u (Reply #6)
Sun Jul 1, 2012, 01:21 PM
TheWraith (24,331 posts)
8. And?
|
You're not confusing this with the substance in the original story, are you?
|
Response to TheWraith (Reply #8)
Sun Jul 1, 2012, 01:23 PM
2on2u (1,843 posts)
9. No I am not but they are using people instead of mice, a step in the right direction.
Response to ZombieHorde (Reply #1)
Sun Jul 1, 2012, 01:45 PM
2on2u (1,843 posts)
11. The university that did the work might be reputable, then there is a previous piece of
|
work they did with simply longevity and overall health status in 2009
http://www.sciencedaily.com/releases/2009/07/090708132800.htm The rapamycin was given to the mice at an age equivalent to 60 years old in humans. The studies are part of the National Institute on Aging (NIA) Interventions Testing Program, which seeks compounds that might help people remain active and disease-free throughout their lives. The other two centers involved are the University of Michigan at Ann Arbor and Jackson Laboratory in Bar Harbor, Maine. The Texas study was led by scientists at two institutes at the UT Health Science Center: the Institute of Biotechnology (IBT) and the Barshop Institute for Longevity and Aging Studies. "I've been in aging research for 35 years and there have been many so-called 'anti-aging' interventions over those years that were never successful," said Arlan G. Richardson, Ph.D., director of the Barshop Institute. "I never thought we would find an anti-aging pill for people in my lifetime; however, rapamycin shows a great deal of promise to do just that." |
Response to 2on2u (Original post)
Sun Jul 1, 2012, 12:50 PM
aint_no_life_nowhere (18,936 posts)
2. Everything seems to improve memory and learning in mice
|
People who keep up with these kinds of stories such as those who have family members with Alzheimer's know that almost on a weekly basis there is some new breakthrough reported on laboratory research dealing with mouse models. The list of potential Alzheimer treatments that have shown promise in treating mice but then proved to have negligible results when tested on humans is long. The problem is that mice and human brains are vastly different.
|
Response to aint_no_life_nowhere (Reply #2)
Sun Jul 1, 2012, 01:14 PM
IDemo (12,290 posts)
5. There's never been a better time to be a laboratory mouse
|
Cancer-free, diabetes-free, and now, gifted learners as well.
|
Response to IDemo (Reply #5)
Sun Jul 1, 2012, 01:18 PM
thelordofhell (3,802 posts)
7. But then how do you explain Pinky?
Response to aint_no_life_nowhere (Reply #2)
Sun Jul 1, 2012, 01:33 PM
2on2u (1,843 posts)
10. From another paper on the same topic (April 1 2010) I know, I know, April fools.... but it isn't
|
Like they just blurted this out, they have been working with it for some time.
http://www.sciencedaily.com/releases/2010/04/100401173730.htm Changing a toxic process "The fact that we are seeing identical results in two vastly different mouse models of Alzheimer's disease," Dr. Galvan added, in reference to the recent study by Caccamo et al, "provides robust evidence that rapamycin treatment is effective and is acting by changing a basic pathogenic process of Alzheimer's that is common to both mouse models. This suggests that it may be an effective treatment for Alzheimer's in humans, who also have very diverse genetic makeup and life histories." |
Response to 2on2u (Original post)
Sun Jul 1, 2012, 01:13 PM
Auntie Bush (15,225 posts)
4. Wow! There is hope for me! nt
Response to 2on2u (Original post)
Sun Jul 1, 2012, 05:30 PM
Quantess (23,894 posts)
12. Interesting.
Response to 2on2u (Original post)
Sun Jul 1, 2012, 05:34 PM
SidDithers (26,957 posts)
13. Aliens?...
|
WTF?
Sid |
Response to SidDithers (Reply #13)
Sun Jul 1, 2012, 08:03 PM
2on2u (1,843 posts)
14. Whoever put them there rock things up, they are quite heavy you know. n/t
Response to 2on2u (Reply #14)
Sun Jul 1, 2012, 08:06 PM
zappaman (8,319 posts)
15. True.
|
It had to be aliens.
There really is no other explanation. ![]() |
Response to zappaman (Reply #15)
Mon Jul 2, 2012, 06:05 AM
2on2u (1,843 posts)
16. He doesn't beat around the bush, a real one or the one on his head. n/t


